Eculizumab as First-Line Therapy for Atypical Hemolytic Uremic Syndrome

Title
Eculizumab as First-Line Therapy for Atypical Hemolytic Uremic Syndrome
Authors
Keywords
-
Journal
PEDIATRICS
Volume 133, Issue 6, Pages e1759-e1763
Publisher
American Academy of Pediatrics (AAP)
Online
2014-05-20
DOI
10.1542/peds.2013-1787

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search